Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-09-02 Sale | 2022-09-07 4:26 pm | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 15,355 | $39.57 | $607,597 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-11 Option Award | 2024-03-12 6:41 pm | N/A 2034-03-10 | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2023-03-10 Option Award | 2023-03-14 4:25 pm | N/A 2033-03-09 | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 120,000 | $0 | 120,000 (Direct) | View |
| 2022-09-02 Exercise | 2022-09-07 4:26 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 6,511 | $4.75 | 0 (Direct) | View |
| 2022-09-02 Tax Withholding | 2022-09-07 4:26 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 3,293 | $39.53 | 0 (Direct) | View |
| 2022-09-02 Exercise | 2022-09-07 4:26 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 9,000 | $9.44 | 0 (Direct) | View |
| 2022-09-02 Exercise | 2022-09-07 4:26 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 813 | $8.4 | 0 (Direct) | View |
| 2022-09-02 Exercise | 2022-09-07 4:26 pm | N/A 2029-09-15 | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 18,648 | $0 | 0 (Direct) | View |
| 2022-09-02 Exercise | 2022-09-07 4:26 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 32 | $7.49 | 0 (Direct) | View |
| 2022-09-02 Exercise | 2022-09-07 4:26 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 2,292 | $3.1 | 0 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 4:11 pm | N/A 2032-03-09 | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 125,000 | $0 | 125,000 (Direct) | View |
| 2021-06-03 Option Award | 2021-06-03 4:42 pm | N/A 2031-06-02 | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 100,000 | $0 | 100,000 (Direct) | View |
Ownership | 2021-06-03 4:35 pm | N/A N/A | Xenon Pharmaceuticals Inc. | XENE | AULIN SHERRY Chief Financial Officer | 0 | $0 | 71,982 (Direct) | View |